Delivery of antiemetics through an inhalation route
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-009/12
A61K-009/72
출원번호
US-0150591
(2002-05-17)
발명자
/ 주소
Rabinowitz, Joshua D.
Zaffaroni, Alejandro C.
출원인 / 주소
Alexza Molecular Delivery Corporation
대리인 / 주소
Stracker Elaine C.
인용정보
피인용 횟수 :
61인용 특허 :
19
초록▼
The present invention relates to the delivery of antiemetics through an inhalation route. Specifically, it relates to aerosols containing antiemetics that are used in inhalation therapy. In a composition aspect of the present invention, the aerosol comprises particles comprising at least 5 percent b
The present invention relates to the delivery of antiemetics through an inhalation route. Specifically, it relates to aerosols containing antiemetics that are used in inhalation therapy. In a composition aspect of the present invention, the aerosol comprises particles comprising at least 5 percent by weight of an antiemetic. In a method aspect of the present invention, an antiemetic is delivered to a mammal through an inhalation route. The method comprises: a) heating a composition, wherein the composition comprises at least 5 percent by weight of an antiemetic, to form a vapor; and, b) allowing the vapor to cool, thereby forming a condensation aerosol comprising particles, which is inhaled by the mammal. In a kit aspect of the present invention, a kit for delivering an antiemetic through an inhalation route to a mammal is provided which comprises: a) a composition comprising at least 5 percent by weight of an antiemetic; and, b) a device that forms an antiemetic aerosol from the composition, for inhalation by the mammal.
대표청구항▼
1. A composition for delivery of an antiemetic comprising a condensation aerosola) formed by volatilizing an antiemetic under conditions effective to produce a heated vapor of the antiemetic and condensing the heated vapor of the antiemetic to form condensation aerosol particles;b) wherein said cond
1. A composition for delivery of an antiemetic comprising a condensation aerosola) formed by volatilizing an antiemetic under conditions effective to produce a heated vapor of the antiemetic and condensing the heated vapor of the antiemetic to form condensation aerosol particles;b) wherein said condensation aerosol particles are characterized by less than 5% antiemetic degradation products, andc) the aerosol has an MMAD less than 3 microns. 2. A composition for delivery dolasetron, granisetron or metoclopramide comprising a condensation aerosola) formed by volatilizing dolasetron, granisetron or metoclopramide under conditions effective to produce a heated vapor of dolasetron, granisetron or metoclopramide and condensing the heated vapor of the dolasetron, granisetron or metoclopramide to form condensation aerosol particles;b) wherein said condensation aerosol particles are characterized by less than 5% dolasetron, granisetron or metoclopramide degradation products, andc) the aerosol has an MMAD less than 3 microns. 3. The composition according to claim 2, wherein the condensation aerosol particles comprise less than 2.5 percent by weight of dolasetron, granisetron or metoclopramide degradation products. 4. The composition according to claim 2, wherein the aerosol particles comprise at least 95percent by weight of dolasetron, granisetron or metoclopramide. 5. The composition according to claim 4, wherein the aerosol has a mass median aerodynamic diameter less than 2 microns. 6. The composition according to claim 5, wherein the aerosol particles comprise at least 97 percent by weight of dolasetron, granisetron or metoclopramide. 7. A method of producing dolasetron, granisetron or metoclopramide in an aerosol form comprising:a) volatilizing dolasetron, granisetron or metoclopramide under conditions effective to produce a heated vapor of the drug, andb) during said volatilizing, passing air through the heated vapor to produce aerosol particles of the dolasetron, granisetron or metoclopramide comprising less than 5% dolasetron, granisetron or metoclopramide degradation products and an aerosol having an MMAD less than 3 microns. 8. The method according to claim 7, wherein the aerosol particles are formed at a rate of greater than 0.5 mg/sec. 9. The method according to claim 7, wherein said volatilizing includes heating a thin layer comprising dolasetron, granisetron or metoclopramide on a solid support having the surface texture of a metal foil, to a temperature sufficient to volatilize dolasetron, granisetron or metoclopramide from the thin layer. 10. The method according to claim 7, wherein the aerosol particles comprise less than 2.5 percent by weight of dolasetron, granisetron or metoclopramide degradation products. 11. The method according to claim 9, wherein the aerosol particles comprise at least 95 percent by weight of dolasetron, granisetron or metoclopramide. 12. The method according to claim 11, wherein the aerosol has a mass median aerodynamic diameter less than 2 microns. 13. The method according to claim 12, wherein the aerosol particles comprise at least 97 percent by weight of dolasetron, granisetron or metoclopramide. 14. A method of producing an antiemetic in an aerosol form comprising:a) volatilizing an antiemetic under conditions effective to produce a heated vapor of the antiemetic, andb) during said volatilizing, passing air through the heated vapor to produce aerosol particles of the antiemetic comprising less than 5% antiemetic degradation products and an aerosol having an MMAD less than 3 microns.
Rubsamen Reid M. (Berkeley CA) Lloyd Lester J. (Orinda CA) Johansson Eric T. (Dublin CA), Lockout device for controlled release of drug from patient-activated dispenser.
Lloyd Lester J. (Orinda CA) Lloyd Peter M. (Oakland CA) Rubsamen Reid M. (Berkeley CA) Schuster Jeffrey A. (Berkeley CA), Systems for the intrapulmonary delivery of aerosolized aqueous formulations.
Hale, Ron L.; Lei, Mingzu; Lloyd, Peter M.; Munzar, Patrik; Sharma, Krishnamohan; Solas, Dennis W.; Stracker, Matthew D., Aerosol drug delivery device incorporating percussively activated heat packages.
Hale,Ron L.; Rabinowitz,Joshua D.; Solas,Dennis W.; Zaffaroni,Alejandro C., Delivery of compounds for the treatment of headache through an inhalation route.
Hale, Ron L.; Hodges, Craig C.; Lloyd, Peter M.; Lu, Amy T.; Myers, Daniel J.; Rabinowitz, Joshua D.; Wensley, Martin J.; McKinney, Jeffrey A.; Zaffaroni, Alejandro C., Drug condensation aerosols and kits.
Hale, Ron L.; Hodges, Craig C.; Lloyd, Peter M.; Lu, Amy T.; Myers, Daniel J.; Rabinowitz, Joshua D.; Wensley, Martin J.; McKinney, Jeffrey A.; Zaffaroni, Alejandro C., Drug condensation aerosols and kits.
Hale, Ron L.; Hodges, Craig C.; Lloyd, Peter M.; Lu, Amy T.; Myers, Daniel J.; Rabinowitz, Joshua D.; Wensley, Martin J.; McKinney, Jeffrey A.; Zaffaroni, Alejandro C., Drug condensation aerosols and kits.
Hale, Ron L.; Hodges, Craig C.; Lloyd, Peter M.; Mufson, Daniel; Rogers, Daniel D.; Song, Soonho; Wensley, Martin J.; Myers, Daniel J.; McKinney, Jeffrey A.; Quintana, Reynaldo J.; Rabinowitz, Joshua D., Method of forming an aerosol for inhalation delivery.
Hale, Ron L.; Hodges, Craig C.; Lloyd, Peter M.; Mufson, Daniel; Rogers, Daniel D.; Song, Soonho; Wensley, Martin J.; Myers, Daniel J.; McKinney, Jeffrey A.; Quintana, Reynaldo J.; Rabinowitz, Joshua D., Method of forming an aerosol for inhalation delivery.
Hale, Ron L.; Hodges, Craig C.; Lloyd, Peter M.; Mufson, Daniel; Rogers, Daniel D.; Song, Soonho; Wensley, Martin J.; Myers, Daniel J.; McKinney, Jeffrey A.; Quintana, Reynaldo J.; Rabinowitz, Joshua D., Method of forming an aerosol for inhalation delivery.
Hale, Ron L.; Hodges, Craig C.; Lloyd, Peter M.; Mufson, Daniel; Rogers, Daniel D.; Song, Soonho; Wensley, Martin J.; Myers, Daniel J.; McKinney, Jeffrey A.; Quintana, Reynaldo J.; Rabinowitz, Joshua D., Method of forming an aerosol for inhalation delivery.
Cross, Stephen D.; Herbette, Mathieu; Kelly, Andrew J. G.; Myers, Daniel J.; Shen, William W.; Timmons, Ryan D.; Tom, Curtis; Virgili, Justin M.; Wensley, Martin J., Multiple dose condensation aerosol devices and methods of forming condensation aerosols.
Cross, Steven D.; Herbette, Mathieu; Kelly, Andrew J. G.; Myers, Daniel J.; Shen, William W.; Timmons, Ryan D.; Tom, Curtis; Virgili, Justin M.; Wensley, Martin J., Multiple dose condensation aerosol devices and methods of forming condensation aerosols.
Hale, Ron L.; Lloyd, Peter M.; Lu, Amy T.; Rabinowitz, Joshua D.; Wensley, Martin J., Respiratory drug condensation aerosols and methods of making and using them.
Damani, Ramesh; Hale, Ron L.; Myers, Daniel J.; Quintana, Reynaldo J.; Solas, Dennis W.; Song, Soonho; Soni, Pravin; Tom, Curtis; Sharma, Kirshnamohan, Self-contained heating unit and drug-supply unit employing same.
Damani, Ramesh; Hale, Ron L.; Myers, Daniel J.; Quintana, Reynaldo J.; Solas, Dennis W.; Song, Soonho; Soni, Pravin; Tom, Curtis; Sharma, Krishnamohan, Self-contained heating unit and drug-supply unit employing same.
Damani, Ramesh; Hale, Ron L.; Myers, Daniel J.; Quintana, Reynaldo J.; Solas, Dennis W.; Song, Soonho; Soni, Pravin; Tom, Curtis; Sharma, Krishnamohan, Self-contained heating unit and drug-supply unit employing same.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.